High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5496-5499

  Antonelli, Alessandro ^a,d   Rotondi, Mario ^b   Fallahi, Poupak ^a   Romagnani, Paola ^c   Ferrari, Silvia Martina ^a   Buonamano, Andrea ^c   Ferrannini, Ele ^a   Serio, Mario ^c  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; CHEMOKINES, CXC; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; THYROIDITIS, AUTOIMMUNE;

EID: 8744246379     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0977     Document Type: Article

References (30)

1. Zlotnik A, Yoshle O 2000 Chemokines: a new classification system and their role in immunity. Immunity 12:121-127
2. Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Hesselgesser J, Horuk R, Strieter RM 1997 The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. J Leukoc Biol 62:554-562
3. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A 2001 Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56
4. Rossi D, Zlotnik A 2000 The biology of chemokines and their receptors. Annu Rev Immunol 18:217-242
5. Cascieri MA, Springer MS 2000 The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr Opin Chem Biol 4:420-427
6. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P 2003 An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 197:1537-1549
7. Romagnani P, Annunziato F, Lasagni L, Lazzeri E, Beltrame C, Francalanci M, Uguccioni M, Galli G, Cosmi L, Maurenzig L, Baggiolini M, Maggi E, Romagnani S, Serio M 2001 Cell cycle dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 107:53-63
8. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L, Tonacchera M, Bellastella A, Serio M 2002 Expression of IP-10/CXCL10 and Mig/CXCL9 in the thyroid and increased serum levels of IP-10/CXCL10 in the serum of subjects with recent onset Graves' disease. Am J Pathol 161:195-206
9. + lymphocytes. J Clin Endocrinol Metab 86:5008-5016
10. Romagnani P, Lazzeri E, Lasagni L, Mavilia C, Beltrame C, Francalanci M, Rotondi M, Annunziato F, Maurenzig L, Cosmi L, Galli G, Salvadori M, Maggi E, Serio M 2002 IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol 13:53-64
11. Rotondi M, Lazzeri E, Romagnani P, Serio M 2003 Role for interferon-γ inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 26:177-180
12. Nicoletti F, Conget I, Di Mauro M, Di Marco R, Mazzarino MC, Bendtzen K, Messina A, Gomis R 2002 Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110
13. Shimada A, Morimoto J, Kodama K, Suzuki R, Oikawa Y, Funae O, Kasuga A, Saruta T, Narumi S 2001 Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24:510-515
14. Antonelli A, Fallahi P, Nesti C, Pupilli C, Marchetti P, Takasawa S, Okamoto H, Ferrannini E 2001 Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease. Clin Exp Immunol 126:426-431
15. Antonelli A, Saracino A, Alberti B, Canapicchi R, Cartei F, Lepri A, Laddaga M, Baschieri L 1992 High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. Acta Endocrinol (Copenh) 126:13-23
16. Antonelli A, Ferri C, Fallahi P 1999 Thyroid cancer in patients with hepatitis C infection. JAMA 281:1588
17. Antonelli A, Miccoli P, Fallahi P, Grosso M, Nesti C, Spinelli C, Ferrannini E 2003 Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. Thyroid 13:479-484
18. 131I therapy. Nucl Med Commun 19:341-346
19. Vitti P 2000 Grey scale thyroid ultrasonography in the evaluation of patients with Graves' disease. Eur J Endocrinol 142:22-24
20. Antonelli A, Miccoli P, Fallahi P, Grosso M, Nesti C, Spinelli C, Ferrannini E 1995 Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid 5:25-29
21. Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A, Bartolozzi C, Pinchera A, Martino E 1995 Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. J Endocrinol Invest 18:857-861
22. Baschieri L, Antonelli A, Nardi S, Alberti B, Lepri A, Canapicchi R, Fallahi P 1997 Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy. Thyroid 4:579-585
23. Davies TF, Greenberg D, Tomer Y 2003 The genetics of the autoimmune thyroid diseases. Ann Endocrinol (Paris) 64:28-30
24. Weetman AP 2003 Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148:1-9
25. Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S, Baker Jr JR 2002 A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transform nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 168:2470-2474
26. Caturegli P, Hejazi M, Suzuki K, Dohan O, Carrasco N, Kohn LD, Rose NR 2000 Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid. Proc Natl Acad Sci USA 97:1719-1724
27. Stassi G, De Maria R 2002 Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2:195-204
28. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman AP 2003 Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 59:207-213
29. Lalor PF, Shields P, Grant A, Adams DH 2002 Recruitment of lymphocytes to the human liver. Immunol Cell Biol 80:52-64
30. Rotondi M, Rosati A, Buonamano A, Lasagni L, Lazzeri E, Pradella F, Fossombroni V, La Villa G, Serio M, Bretoni E, Salvatori M, Romagnani P 2004 High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of allograft failure. Am J Transplant 4:1466-1474